RiaSTAP™ (fibrinogen concentrate [human]) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia.
Treatment For Congenital Fibrinogen Deficiency
Treatment For Congenital Fibrinogen Deficiency
2024-06-12
RiaSTAP™ (fibrinogen concentrate [human]) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia.